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n vivo cellular and molecular imaging of the stem cells has been developed to characterize the biological processes at the most fundamental level in an intact, living organism. With the emergence of cell-based therapy in a failing heart, the capability to evaluate engraftment and survival of the transplanted stem cells in vivo represents a critical measure of therapeutic efficacy. The stem cells at the very least must survive to restore the injured myocardium. 1, 2 Cell viability signal holds physiological relevance because it may correlate with the resultant myocardial restoration. There are 2 primary considerations for in vivo imaging of stem cell viability in the heart: (1) amplification of molecular and cellular signals and (2) high spatial and temporal resolution imaging of the myocardium. It is widely acknowledged that there is no single imaging modality that will fulfill all needs of in vivo stem cell imaging. However, an imaging modality that optimizes the technical objectives may extract meaningful information on cellular and molecular events of the transplanted cells. The predominant imaging modalities to assess stem cell survival in vivo in preclinical models consist of radionuclide imaging, optical imaging, and MRI. These modalities are commonly used in small animal models. Direct transfer of in vivo cellular and molecular imaging techniques from small to large animal models, however, has not been straightforward.
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The report by Templin et al 3 in this issue of Circulation addresses the critical issue of in vivo imaging of stem cell viability in a porcine myocardial injury model. The study evaluated sodium iodide symporter (NIS) transgene to follow in vivo survival of human induced pluripotent stem cells (hiPSCs) and their derivatives. A stable transgenic hiPSC line expressing a fluorescent reporter and NIS (NIS pos -hiPSCs) was used. Longitudinal dual isotope single-photon emission computed tomography (SPECT)-computed tomography imaging was applied using 123 I to follow donor cell survival and distribution.
99m TC-tetrofosmin was subsequently used for myocardial perfusion imaging. In vivo, viable NIS pos -hiPSCs were visualized near the injection sites for up to 15 weeks. The in vivo data were validated by immunohistochemistry, which demonstrated that the hiPSC-derived endothelial cells contributed to intramyocardial revascularization. Up to 12 to 15 weeks after transplantation, no undifferentiated hiPSCs or teratoma was detected.
Translation of stem cell technology requires a systematic validation, progressing from a small to large animal model. To conduct these preclinical studies, different imaging modalities are used to assess stem cell engraftment and survival. First, positron-emission tomography (PET) and SPECT are highly sensitive systems, which detect trace amounts of ␥-and ␤-emitting radionuclide well suited for tracking systemic biodistribution of cellular and molecular signals. The sensitivity of PET is very high in the range of 10
mol/L and is at least 1 to 2 orders of magnitude better than SPECT. 2 Advanced molecular imaging applications using various techniques including radiolabeled ligand, antibody, and reporter gene have been developed. 4, 5 Second, the most successful optical method for imaging small numbers of transplanted cells in experimental models is bioluminescence imaging. The sensitivity reaches 10 Ϫ15 to 10 Ϫ17 mol/L. 6 This modality uses an internal biological light source, such as luciferase, which can be detected within the tissues of small animals using sensitive low-light imaging systems and has allowed localization and tracking of as few as 10 3 cells. 5,7-9 While optical imaging detects signals from near-cellular level, this technique is limited to small animal imaging because of depth penetration of 1 to 2 cm. 8 Third, MRI combines chemical sensitivity of nuclear magnetic resonance with high spatial and temporal resolution. It routinely offers submillimeter resolution with temporal resolution in the millisecond range and intrinsically superior contrast mechanism. These specifications provide optimal technical characteristics to assess myocardial physiology. However, MRI is several magnitudes less sensitive than radionuclide imaging or optical imaging, only capable of detecting molecular signal in the range of 10 Ϫ3 to 10 Ϫ5 mol/L, presenting limited options for MRI molecular probes. 6 Ex vivo cell labeling with iron oxide, nevertheless, has improved the MRI sensitivity several fold to 10 Ϫ9 to 10 Ϫ11 mol/L range, approaching the sensitivity of SPECT. 10 Novel imaging sequences, higher magnetic fields, hardware development, and targeted contrast agents have enabled in vivo MRI to combine molecular and cellular signals with precise 3-dimensional and 4-dimensional characterization of the target organ. 11 While Templin et al 3 To answer these questions, other available imaging options need to be explored. Although the investigators are commended for using SPECT, which is more accessible to the cardiology community, a more definitive alternative is PET. 18 F-fluorodeoxyglucose ( 18 F-FDG) prelabeled cells will allow a robust quantification of immediate stem cell engraftment in vivo in a porcine model. 12 However, the approach is limited by the short half-life of only 110 minutes. For longitudinal monitoring, 111 In-labeled SPECT imaging of cells has a half-life of 2.8 days, enabling a follow-up of 2 weeks after cell delivery. 13 However, 111 In-labeling is known to be toxic to cells, allowing labeling of only a limited percentage of the delivered cells. A more long-term strategy, allowing serial monitoring in a large animal model, is the PET herpes simplex virus-thymidine kinase reporter gene system (HSV-tk). 5 In this system, the HSV-tk reporter gene is integrated into the cell genome. Although HSV-tk has been demonstrated robustly in small animals, only recently, longitudinal expression (up to 5 months) of HSV-tk has been reported after transplantation of HSV-tk transduced MSCs in a porcine myocardial injury model. 14 A feasible alternative to HSV-tk is the NIS system reported in this issue. One of the advantages of NIS is that it uses an endogenous mammalian gene generating minimal immunogenic response in comparison with HSV-tk. 3 Before this study by Templin et al, 3 successful demonstration of NIS was also limited to small animals.
Another commonly used imaging option to localize stem cells in a large animal model is MRI. Earlier techniques required ex vivo labeling of the stem cells to detect successful delivery and subsequent migration using iron oxide-based agents. 15 The robust negative contrast generated by iron oxide agents has enabled reliable cell labeling. Use of nanoparticles of iron oxide covalently bound to HIV-1 tat-peptide, antitransferrin receptor, and transfection agents such as poly-Llysine and protamine sulfate have demonstrated efficient intracellular labeling. [15] [16] [17] Studies have also reported successful tracking at near single-cell resolution. 18 Although iron oxide nanoparticles have been used to localize the transplanted stem cells reliably, ex vivo cell labeling with these agents does not detect stem cell viability. 19 To assess their survival, several approaches have been proposed in MR molecular imaging. The first approach uses a reporter gene mechanism which uses promoter genes to induce specific gene expression. This system exploited conformational change of a Gd-containing compound to be induced by enzymatic cleavage to interact with water protons to generate T 1 shortening effects. 20 The second approach integrates reporter system consisting of genetically engineered cells to overexpress transferrin receptors. 21 The receptors accumulate the iron particles intracellularly to generate T 2 -weighted signal. The third approach uses iron oxide-tagged monoclonal antibodies to detect a certain end product of molecular expression. 22 This targeted, antibody-mediated approach to molecular MRI has been demonstrated successfully in a murine myocardial injury model. 23 Finally, nongenomic technique has been developed using manganese-enhanced MRI. Manganese-enhanced MRI uses an essential heavy metal ion, Mn 2ϩ , which enters the viable cells via voltage-gated calcium channels. 24 Intracellular accumulation of Mn 2ϩ shortens T 1 relaxation time to generate positive signal. Manganeseenhanced MRI combines the high spatial and temporal resolution of MRI with cell viability specific signal to enable dual assessment of myocardial restoration and stem cell viability. Successful demonstration of this technique has been reported in small and large animal studies. [25] [26] [27] [28] Many in vivo imaging studies have reported limited engraftment of stem cells, mostly dying after transplantation. 29 However, other studies have demonstrated that the stem cells delivered into the myocardium do survive and demonstrate robust viability in both murine and porcine myocardium. Mouse endothelial stem cells delivered into 3 regions (remote, peri-, and intrainfarct) of myocardial injury exhibited differential survival and restorative potential. 30 Furthermore, improved survival of mouse endothelial stem cells compared with mouse embryonic fibroblasts shown by in vivo bioluminescence imaging and validated by polymerase chain reaction analysis for the male Sry gene, correlated increased survival of mouse endothelial stem cells with enhanced myocardial restoration. 31 In a porcine model, enhanced survival of MSCs demonstrated by manganese-enhanced MRI and PET correlated with improved myocardial function. 14, 28 Furthermore, this study by Templin et al 3 confirms survival of transplanted hiPSCs when optimized by the MSCs. Although there are conflicting data on in vivo stem cell survival, these studies offer promise to cell therapy in cardiovascular diseases.
Stem cell research stands at a critical juncture where systematic translation of basic discoveries will be crucial. Recent development in nuclear reprogramming of human skin cells to generate pluripotent stem cells and directed differentiation of human embryonic stem cells to cardiomyocytes may lead to significant clinical breakthrough. 32, 33 These advances, however, require rigorous in vivo validation. In vivo imaging represents a dedicated platform to evaluate and quantitate molecular and cellular events related to cellular engraftment, a critical step in regenerative medicine. This integrative approach should enable systematic translation of basic stem cell science to clinical application.
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